Literature DB >> 7492179

Evidence for superantigen mediated process in Kawasaki disease.

J De Inocencio, R Hirsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7492179      PMCID： PMC1511292          DOI： 10.1136/adc.73.3.275-b

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  6 in total

1.  Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.

Authors:  A Nishiyori; M Sakaguchi; H Kato; H Igarashi; K Miwa
Journal:  Lancet       Date:  1994-01-29       Impact factor: 79.321

2.  Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): preferential production of tumour necrosis factor-alpha (TNF-alpha) by V beta 2- or V beta 8- CD4+ T helper cells.

Authors:  M Sakaguchi; H Kato; A Nishiyori; K Sagawa; K Itoh
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

3.  Evidence for a superantigen mediated process in Kawasaki disease.

Authors:  N Curtis; R Zheng; J R Lamb; M Levin
Journal:  Arch Dis Child       Date:  1995-04       Impact factor: 3.791

4.  TCR V beta family repertoire and T cell activation markers in Kawasaki disease.

Authors:  B A Pietra; J De Inocencio; E H Giannini; R Hirsch
Journal:  J Immunol       Date:  1994-08-15       Impact factor: 5.422

5.  Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease.

Authors:  J Abe; B L Kotzin; K Jujo; M E Melish; M P Glode; T Kohsaka; D Y Leung
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

6.  Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.

Authors:  D Y Leung; H C Meissner; D R Fulton; D L Murray; B L Kotzin; P M Schlievert
Journal:  Lancet       Date:  1993-12-04       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.